FDA Adverse Event Malfunction Summary report: N

ALINITY C PROCESSING MODULE

MDR report key: 11641264 · Received April 9, 2021

Report

Report Number
3002809144-2021-00241
Event Type
Malfunction
Date Received
April 9, 2021
Date of Event
March 19, 2021
Report Date
May 27, 2021
Manufacturer
ABBOTT GMBH
Product Code
JJE
UDI-DI
00380740137380
PMA / PMN Number
EXEMPT
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

THIS FOLLOW UP IS SUBMITTED TO POPULATE FIELDS D8 AND/OR H6 WITH DATA THAT HAD PREVIOUSLY BEEN PROVIDED IN FIELD H10. THERE IS NO CHANGE TO THE CONTENT OF THE DATA.

Additional Manufacturer Narrative · 1

WAS THIS DEVICE SERVICED BY A THIRD PARTY? NO. PATIENT IDENTIFIER COMPLETE ENTRY = SAMPLE ID (B)(6), SAMPLE ID (B)(6), AND SAMPLE ID (B)(6) ALL AVAILABLE PATIENT INFORMATION WAS INCLUDED. ADDITIONAL PATIENT DETAILS ARE NOT AVAILABLE. AN ABBOTT FIELD SERVICE REPRESENTATIVE (FSR) WAS DISPATCHED DUE TO THE CUSTOMER REPORTING FALSELY DEPRESSED SODIUM AND POTASSIUM RESULTS ON THE ALINITY C, SERIAL NUMBER (B)(4). THROUGH AN EXTENSIVE INVESTIGATION, THE FSR FOUND THE ALINITY C-SERIES CUVETTE, LIST NUMBER 04S47-01, NEEDED TO BE REPLACED, WHICH RESOLVED THE CUSTOMER¿S COMPLAINT. NO SUBSEQUENT ISSUES HAVE BEEN REPORTED. A REVIEW OF THE INSTRUMENT HISTORY REVEALED NO CONTRIBUTING FACTORS DESCRIBED IN THIS COMPLAINT. A REVIEW OF LABELING AND HISTORICAL DATA WAS DONE, AND BOTH WERE ADEQUATE, WITH NO TRENDS FOUND. BASED ON ALL AVAILABLE INFORMATION AND ABBOTT DIAGNOSTICS' COMPLAINT INVESTIGATION, NO SYSTEMIC ISSUE OR PRODUCT DEFICIENCY WAS IDENTIFIED.

Description of Event or Problem · 1

THE CUSTOMER OBSERVED FALSELY DECREASED SODIUM (NA) AND POTASSIUM (K) RESULTS FOR SEVERAL PATIENTS ON AN ALINITY C ANALYZER. THE FOLLOWING DATA WAS PROVIDED (CUSTOMER¿S REFERENCE RANGE FOR SODIUM IS 125-149 MMOL/L; FOR POTASSIUM IS 2.6-6.4 MMOL/L): SAMPLE ID (B)(6) INITIAL NA RESULT, ON (B)(6) 2021, WAS 117, REPEAT RESULT WAS 141 MMOL/L SAMPLE ID (B)(6) INITIAL NA RESULT, ON (B)(6) 2021, WAS 113, REPEAT RESULTS WERE 138 AND 141 MMOL/L. THE SAMPLE WAS REPEATED ON THE BLOOD GAS INSTRUMENT AND THE RESULT WAS 136.9 MMOL/L. SAMPLE ID (B)(6) INITIAL K RESULT, ON (B)(6) 2021, WAS 3.3, REPEAT RESULTS WERE 2.5, 3.3, AND 3.3 MMOL/L. THE SAMPLE WAS REPEATED ON THE BLOOD GAS INSTRUMENT AND THE RESULT WAS 3.22 MMOL/L. THERE WAS NO IMPACT TO PATIENT MANAGEMENT REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
539046 ALINITY C PROCESSING MODULE ANALYZER, CHEMISTRY (PHOTOMETRIC, DISCRETE), FOR CLINICAL USE JJE ABBOTT GMBH 03R6701 00380740137380

Patients

Seq Age Sex Outcome Treatment
1